IMDX
Insight Molecular Diagnostics
IMDX
IMDX
25 hedge funds and large institutions have $12.8M invested in Insight Molecular Diagnostics in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 9 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
4% less funds holding
Funds holding: 26 → 25 (-1)
78% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 9
Holders
25
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$2.79K | |
| 2 | +$1K | |
| 3 | +$38 | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$3 |
Top Sellers
| 1 | -$360K | |
| 2 | -$185K | |
| 3 | -$46.2K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.25K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.51K |